A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment

Kyuson Yun, Ph.D.
Associate Professor
Department of Neurology
Houston Methodist Chair, Neurodegenerative Disease Research
Houston Methodist Research Institute
Weill Cornell Medical College
Pioneers in Biomedical Research Seminar
A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment
Date: May 2, 2025
Time: 11 a.m. - 12 p.m.
About this Seminar
While immunotherapies have shown remarkable efficacy in some cancers, most solid tumors, including brain cancers, are resistant to immunotherapies. Immunotherapies are ideal for treating brain cancers since immune cells can cross the blood brain barrier (BBB) and track and selectively kill infiltrating brain cancer cells while sparing normal brain cells. Unfortunately, most brain cancer trials with immunotherapies have failed to demonstrate significant benefits to brain cancer patients thus far. Dr. Yun and her team recently identified S100A4 as a critical regulator of immune suppressive myeloid and T cells in GBM through single cell sequencing analysis, and developed a novel S100A4 blocking antibody. To enhance BBB penetration, we also developed a bispecific antibody that crosses the BBB and reprograms the GBM TME to more an inflammatory state. Dr. Yun will discuss our progress in understanding the immune suppressive microenvironment in GBM and the therapeutic potential of a novel bispecific antibody for treating brain cancers.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Center — Roanoke. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home ItemThe Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function , home
Oct. 3, 2025, 11:00 a.m. | Paule Valery Joseph, Ph.D., Lasker Clinical Research Scholar, NIH Distinguished Scholar; Acting Chief, Section of Sensory Science and Metabolism Unit, Co-Director of the National Smell and Taste Center, National Institute on Deafness and Other Communication Disorders; National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and Addiction Recovery Research Center
-
Home ItemOrganization and Control of Hippocampal Networks , home
Oct. 17, 2025, 11:00 a.m. | Ivan Soltesz, Ph.D., James R. Doty Professor of Neurosurgery and Neurosciences, Stanford University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home ItemMaury Strauss Distinguished Public Lecture , home
Oct. 30, 2025, 5:30 p.m. (Reception at 5 p.m.) | Jennifer Munson, Ph.D., Professor and Director, Cancer Research Center — Roanoke, Fralin Biomedical Research Institute; Professor, Department of Biomedical Engineering and Mechanics, Virginia Tech College of Engineering | Maury Strauss Distinguished Public Lecture
-
Home ItemThinking the Right Thoughts , home
Oct. 31, 2025, 11 a.m. | Nathaniel Daw, Ph.D., Professor, Computational and Theoretical Neuroscience, Department of Psychology, Princeton University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
-
Home ItemMaury Strauss Distinguished Public Lecture , home
Nov. 6, 2025, 5:30 p.m. (Reception at 5 p.m.) | Teresa Lambe, Ph.D., OBE, Calleva Head of Vaccine Immunology, Professor of Vaccinology and Immunology, University of Oxford | Maury Strauss Distinguished Public Lecture
-
Home ItemUnderstanding Vascular Morphogenesis and Morphology: Live Insights from Zebrafish , home
Nov. 21, 2025, 11:00 a.m. | Arndt F. Siekmann, Ph.D., Associate Professor, Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania | Co-Sponsored by the Center for Vascular and Heart Research, Fralin Biomedical Research Institute